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Reference Lowest (-3SD) Limit 32PD6/pH6.9/Gal6
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➢ A platform technology based on state of art analytical techniques is established for
biosimilar development
➢ Cell line development for three different biosimilar mAbs are successfully completed
➢ Upstream & Downstream development of two biosimilar products are completed at small
scale (3L)
➢ 200L GMP batch of one biosimilar mAb is currently in progress for Phase I study
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